In summary, our study provided an 8-mRNA signature system to predict the prognosis of PAAD and identified three genes (CA9, CXCL9, and GIMAP7) that were associated with immunocyte infiltration. This evidence concerns the gene CXCL9 and pancreatic adenocarcinoma.